Subject Index To Volume 7
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
85-97
Author(s):
Science Publishers Bentham
Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
1-17
Author(s):
M. A. Jordan
Delivery of Anti-Viral Nucleoside Analogues to the Central Nervous System
Journal:
Current Medicinal Chemistry - Anti-Infective Agents
Volume:
1
Page:
55-63
Author(s):
Tetsuya Hasegawa and Takeo Kawaguchi
Pharmacology of Appetite Suppression: Implication for the Treatment of Obesity
Journal:
Current Drug Targets
Volume:
2
Page:
353-370
Author(s):
Jason C. G. Halford
Gene Therapy: Optimising DNA Delivery to the Nucleus
Journal:
Current Drug Targets
Volume:
2
Page:
371-399
Author(s):
Melanie Johnson-Saliba and David A. Jans
The Ca2+-Activated K+ Channel of Intermediate Conductance:A Molecular Target for Novel Treatments?
Journal:
Current Drug Targets
Volume:
2
Page:
401-422
Author(s):
B. S. Jensen, D. Strobaek, S.-P. Olesen and P. Christophersen
Non-Hodgkins Lymphoma: Review of Conventional Treatments
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
279-291
Author(s):
P. Multani, C.A. White and A. Grillo-Lopez
Zevalin™: 90Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin ’ s Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
341-349
Author(s):
C. Krasner and R.M. Joyce
Monoclonal Antibodies in the Treatment of Hematologic Malignancies: Radiation Dosimetry Aspects
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
351-356
Author(s):
M.G. Stabin and A.B. Brill
Turner Syndrome : How Is It Made Up?
Journal:
Current Genomics
Volume:
2
Page:
357-377
Author(s):
Tsutomu Ogata